Indications for Continuous IV Calcium for Correction of Hypocalcemia
Continuous intravenous calcium is indicated for symptomatic hypocalcemia and severe hypocalcemia with ionized calcium levels below 0.8 mmol/L, particularly in the setting of massive transfusion, trauma, or when cardiac dysrhythmias are present. 1
Primary Indications
- Symptomatic hypocalcemia: Patients presenting with neuromuscular irritability, tetany, seizures, or cardiac dysrhythmias require immediate IV calcium correction 2
- Severe hypocalcemia: Ionized calcium levels below 0.8 mmol/L are associated with cardiac dysrhythmias and require prompt correction 1
- Transfusion-induced hypocalcemia: Particularly during massive transfusion when citrate-mediated chelation of serum calcium occurs 1
- Trauma patients with hypocalcemia: Low calcium concentrations at admission are associated with platelet dysfunction, decreased clot strength, increased blood transfusion requirements, and higher mortality 1
- Acute symptomatic hypocalcemia: As specified in FDA labeling for calcium preparations 3, 4
Clinical Scenarios Requiring Continuous IV Calcium
- Massive transfusion protocols: Each unit of packed red blood cells or fresh frozen plasma contains approximately 3g of citrate that chelates calcium 1
- Hemorrhagic shock: Liver function is often impaired due to hypoperfusion, resulting in decreased citrate metabolism and persistent hypocalcemia 1
- Critical bleeding: Hypocalcemia within the first 24 hours of critical bleeding can predict mortality and need for multiple transfusions 1
- Moderate to severe hypocalcemia (ionized Ca²⁺ <1.0 mmol/L): Short-term infusion of 4g calcium gluconate has been shown to be effective in critically ill trauma patients 5
Administration Considerations
- Calcium chloride is preferred over calcium gluconate in emergency situations and in patients with liver dysfunction 1
- 10mL of 10% calcium chloride contains 270mg of elemental calcium
- 10mL of 10% calcium gluconate contains only 90mg of elemental calcium
- Continuous infusion rate: Typically 1g/hour for calcium gluconate in small volume admixture 6, 5
- Monitoring: Ionized calcium levels should be monitored frequently during continuous infusion 6
- Caution: Do not administer calcium and sodium bicarbonate through the same line due to precipitation risk 1
Special Populations
Chronic Kidney Disease Patients
- An individualized approach should be used for hypocalcemia in CKD patients 1
- Significant or symptomatic hypocalcemia should be corrected, but routine correction of mild hypocalcemia (especially during calcimimetic treatment) is not universally recommended 1
Tumor Lysis Syndrome
- For asymptomatic hypocalcemia in tumor lysis syndrome, no intervention is recommended 1
- Symptomatic patients may be treated with calcium gluconate 50-100 mg/kg IV, administered slowly with ECG monitoring 1
- Caution is needed with high phosphate levels due to risk of calcium phosphate precipitation 1
Monitoring During Therapy
- ECG monitoring: Particularly important during rapid calcium administration 1
- Frequent ionized calcium measurements: To titrate therapy and avoid hypercalcemia 6, 5
- Phosphate levels: Monitor concurrently as high phosphate levels increase risk of calcium phosphate precipitation 1